Human leucocyte antigen DQ alpha heterodimers and human leucocyte antigen DR alleles in tubulointerstitial nephritis and uveitis syndrome.
Li
Jordan Yz
JY
Department of Nephrology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
Yong
Tuck Y
TY
Bennett
Greg
G
Barbara
Jeffrey A
JA
Coates
P Toby H
PT
D000293:Adolescent; D000483:Alleles; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D006683:HLA-DQ Antigens / Q000235:genetics*; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006239:Haplotypes; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008875:Middle Aged; D009395:Nephritis, Interstitial / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology; D010641:Phenotype; D011239:Prednisolone / Q000627:therapeutic use; D055503:Protein Multimerization; D016896:Treatment Outcome; D014605:Uveitis / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; C069050:HLA-DQA1 antigen; C069051:HLA-DQB1 antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; C497841:HLA-DRB1*01 antigen; D011239:Prednisolone